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Abstract. This study aimed to provide a detailed evaluation and comparison of
a range of modulated beam evaluation metrics, in terms of their correlation with
QA testing results and their variation between treatment sites, for a large number of
treatments. Ten metrics including the modulation index (MI), fluence map complexity
(FMC), modulation complexity score (MCS), mean aperture displacement (MAD) and
small aperture score (SAS) were evaluated for 546 beams from 122 IMRT and VMAT
treatment plans targeting the anus, rectum, endometrium, brain, head and neck and
prostate. The calculated sets of metrics were evaluated in terms of their relationships
to each other and their correlation with the results of electronic portal imaging based
quality assurance (QA) evaluations of the treatment beams. Evaluation of the MI,
MAD and SAS suggested that beams used in treatments of the anus, rectum, head
and neck were more complex than the prostate and brain treatment beams. Seven
of the ten beam complexity metrics were found to be strongly correlated with the
results from QA testing of the IMRT beams (p < 0.00008). For example, Values of
SAS (with MLC apertures narrower than 10 mm defined as “small”) less than 0.2 also
identified QA passing IMRT beams with 100% specificity. However, few of the metrics
are correlated with the results from QA testing of the VMAT beams, whether they were
evaluated as whole 360◦ arcs or as 60◦ sub-arcs. Select evaluation of beam complexity
metrics (at least MI, MCS and SAS) is therefore recommended, as an intermediate step
in the IMRT QA chain. Such evaluation may also be useful as a means of periodically
reviewing VMAT planning or optimiser performance.
PACS numbers: 87.55.Qr, 87.53.Bn, 87.55.-x
Submitted to: Phys. Med. Biol.
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1. Introduction
Inverse-planned modulated radiotherapy treatments (including intensity modulated
radiotherapy, IMRT, and volumetric modulated arc therapy, VMAT) are difficult to
evaluate and interpret, arising from optimisation algorithms that attempt to balance
conflicting dosimetric goals despite unavoidable geometric constraints (Webb 2003).
Based on user-accessible variables in the treatment planning system, it can be difficult
to predict the likely success or failure of a given treatment plan when submitted to
pre-treatment quality assurance (QA) testing. It can be similarly difficult to identify
the reasons for QA failures.
The number of MU per beam or the total MU per Gy delivered can be used as a
surrogate for beam complexity or a simplistic indicator of the presence of excessive
numbers of small apertures or closed MLC leaves in the treatment plan (Tonigan
et al. 2011, Tonigan 2011, Miura et al. 2014), but there remains a manifest need for
users to be able to directly and independently evaluate plan deliverability prior to QA
testing.
This need has been answered, in recent years, by the development of a small
number of metrics for assessing modulated plan complexity, deliverability and dose
calculation accuracy; some of these metrics have been correlated with QA results via
small studies (McNiven et al. 2010, Jørgensen et al. 2011, McGarry et al. 2011, Tonigan
et al. 2011, Tonigan 2011, Kairn et al. 2014, Crowe et al. 2014).
For example, McNiven et al. (2010) developed the modulation complexity score
(MCS), which analyses MLC positions to provide an assessment of plan complexity
and deliverability. This metric has been shown to be poorly correlated with phantom
dosimetry QA results when head and neck plans are evaluated (Tonigan et al. 2011,
Tonigan 2011), while also clearly distinguishing between the levels of complexity involved
in treating different anatomical sites (prostate compared to head and neck) (McGarry
et al. 2011).
Similarly, Kairn et al. (2014) developed a number of metrics to quantify specific
parameters expected to lead to dose calculation inaccuracy in the Brainlab iPlan
treatment planning system (Brainlab, Feldkirchen, Germany). While some of these
metrics produced ambiguous or inconclusive results, the small aperture score (a
calculation of the proportion of the beam that is delivered via MLC apertures smaller
than a given threshold) was shown to correlate with QA data obtained using a
low-resolution diode array system for a small sample of prostate and cranial IMRT
treatments (Kairn et al. 2014).
Recently, the modulation index (MI), developed by (Webb 2003) as a means to
introduce a weighting against fluence complexity into the IMRT inverse planning cost
function, has also been shown to be correlated with the gamma agreement index (GAI)
achieved by IMRT beams planned for delivery in prostate treatments, using the Brainlab
m3 microMLC (Crowe et al. 2014).
To date, however, a comprehensive evaluation of a broad range of metrics, applied
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to a large number of beams designed for treating different treatment sites has been
lacking from the literature. Such an evaluation has the potential to identify those
metrics that are able to provide meaningful information about modulated treatment
beams, to evaluate possible interrelationships between the metrics themselves, and to
establish which metrics behave consistently regardless of anatomical site treated and
which metrics vary between treatment sites. This study therefore aims to provide a
detailed examination of beam complexity, deliverability and accuracy metrics, using
546 beams from 122 IMRT and VMAT treatment plans targeting the anus, rectum,
endometrium, brain, head and neck and prostate. The information produced by this
study may thereafter be used to inform treatment planning, to guide QA testing or as
a QA tool in itself.
2. Methods
2.1. Treatment plans and quality assurance
This study has evaluated 402 beams from 52 IMRT treatment plans for five anatomical
sites as well as 144 beams from 70 VMAT treatment plans for the same sites, as detailed
in table 1. All treatments, using both modalities, were planned over the same 11 month
period. The treatments were planned using the Varian Eclipse treatment planning
system (version 11), using the AAA dose calculation algorithm, and delivered using a
Varian iX linear accelerator, with a Millennium 120-leaf MLC (Varian Medical Systems,
Palo Alto, USA). The VMAT plans used the Varian RapidArc system, with a dose rate
of 600 MU/min and with MLC leaves moving back and forth across each field. The
IMRT plans used the sliding-window technique, with a dose rate of 300 MU/min and
with MLC leaves moving in one direction across each field.
Table 1. Distribution of treatment plan modalities and anatomical sites.
Treatment # IMRT # IMRT # VMAT # VMAT
Site plans beams plans beams
Anus/Rectum 6 79 5 12
Endometrium 3 35 2 4
Brain 10 56 12 24
Head & Neck 3 22 11 24
Prostate 30 210 40 80
Total 52 402 70 144
Routine pre-treatment quality assurance checks were performed for all treatments
listed in table 1 using the Epiqa system (EPIdos, Bratislava, Slovakia), using the GLAaS
dosimetric method (Nicolini et al. 2008). The Epiqa system has been detailed by
Nicolini et al. (2008) and Fogliata et al. (2011), and the sensitivity of the system to
introduced errors explored by Fredh et al. (2013). This system involves the acquisition
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of portal images of each treatment beam, delivered using its planned collimator and
gantry angles (including the whole 360◦ rotations in the VMAT plans), using the Varian
aS1000 EPID (Varian Medical Systems, Palo Alto, USA), which has a 0.39 0.39 mm2
spatial resolution.
During the data acquisition period, the stability of both the linac system (including
MLC performance) and the EPID used to acquire the QA images was verified through
the delivery of a set of four static MLC fields, two VMAT arcs and four IMRT beams
of varying complexity. For reasons unrelated to this study, the four IMRT beams were
delivered twice, at dose rates of 300 MU/min and 600 MU/min, allowing the consistency
of IMRT delivery at different dose rates to be established.
In order to quantify the differences between the EPID images and the corresponding
dose planes exported from the Eclipse treatment planning system, the Epiqa software
was used to calculate gamma agreement indices (GAIs), the percentage of points passing
a gamma evaluation (γ < 1.0) (Low & Dempsey 2003, Wendling et al. 2007) using
standard IMRT quality assurance criteria, γ(3%,3mm) (Ezzell et al. 2009, International
Commission of Radiation Units and Measurements 2010). IMRT treatments are
approved for delivery in this clinic where the mean GAI over all beams is > 90% and no
beam has a GAI < 85%. VMAT treatments are approved for delivery where no beam
has a GAI < 90%. Treatments failing to meet the acceptance criteria were replanned.
The gamma evaluation was performed on the dose values recorded within the collimated
field, using the “CIAO feature” (Fredh et al. 2013).
The gamma evaluations for the plans presented here were repeated with tighter
gamma evaluation criteria, γ(2%,2mm). This re-evaluation was intended to provide
information on the effect of QA test stringency on the spread of the beam metric data.
Linear regression and t-tests were used to determine the nature and significance of the
correlation between GAI for γ(3%,3mm) and γ(2%,2mm). Since the results of this
work showed a linear relationship between the GAIs evaluated using the two different
tolerance levels (see section 4.3), only the more clinically relevant GAI, γ(3%,3mm), has
been plotted against the metric results.
Centres generally perform VMAT quality assurance checks by delivering the whole
360◦ rotations, but it is also possible to divide the arc into sub-arc segments and evaluate
these separately (Nicolini et al. 2008, Ravkilde et al. 2013). Quality assurance checks
have been repeated here for a representative sample of 32 arcs (with varying GAI)
each divided into 60◦ sub-arcs. The GAIs for these beams have been evaluated against
corresponding whole (i.e. 360◦) arc values.
The GAI for each beam was compared against a range of calculated metrics designed
to describe the complexity, deliverability and accuracy of the beam. These metrics were
calculated using the in-house Treatment and Dose Assessor (TADA) software, used
previously in the examination of quality assurance using diode array measurements
(Crowe et al. 2014, Kairn et al. 2014) and the retrospective evaluation of dosimetric
quality in prostate treatments (Crowe et al. 2013). The significance of correlation
between GAI and these metrics was evaluated using F -tests.
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2.2. Complexity metrics
The TADA software uses beam arrangement data to generate intensity fluence maps
representing a 40 × 40 cm2 field at isocentre, with 160 × 160 beam elements (bixels).
This fluence map is used in the calculation of two established complexity metrics: the
FMC and MI.
The FMC metric, proposed by Llacer et al. (2001) evaluates deviations between
adjacent bixels relative to the sum of each bixel. The MI metric, proposed by Webb
(2003), evaluates deviations between adjacent bixels relative to the standard deviation
of the intensity fluence map. The TADA software uses the Nicolini et al. (2007)
implementation of MI calculation (Crowe et al. 2014).
2.3. Deliverability metrics
The MCS was proposed by McNiven et al. (2010) as providing a means of quantifying
the deliverability of modulated treatment plans by directly evaluating the complexity
of the positioning of MLC leaves, rather than the complexity of the fluence map they
are positioned to deliver. The MCS combines an aperture area variability (AAV) score
with a leaf sequence variability (LSV) score, to provide an indication of the planned
mobility of individual MLC leaves during the delivery of the treatment.
2.4. Accuracy metrics
A set of treatment planning system dose calculation accuracy metrics were proposed by
Kairn et al. (2014), specifically for use with the pencil beam dose calculation algorithm
available in the Brainlab iPlan treatment planning system (Brainlab, Feldkrichen,
Germany). These metrics were designed to quantify the parameters identified as most
likely to compromise accurate dose calculations; small field and small segment aperture
sizes (Kairn et al. 2011a, Kairn et al. 2011b), closed MLC leaves below open linac
jaws (Fenoglietto et al. 2011), and small field segments delivered from off-axis positions
(Ahnesjo¨ & Aspradakis 1999, Brainlab AG 2010).
Specifically, Kairn et al. (2014) investigated: the mean field area (MFA), an average
of field area weighted according to the segment monitor units; the mean aperture
displacement (MAD), the mean lateral displacement (away from the central axis) of
the centre of the opening between each pair of MLC leaves; the cross-axis score (CAS),
the proportion of MLC leaves within the jaw aperture that cross the central axis; the
closed leaf score (CLS), the proportion of MLC leaf pairs within the jaw aperture that
are entirely closed; and the small aperture score (SAS), the proportion of open MLC
leaf pairs that are separated by less than a given threshold difference, in each beam.
The evaluation of these metrics and their use with treatment plans from the Brainlab
iPlan treatment planning system is further detailed in Crowe et al. (2014). A list of
these initialisms is provided as an appendix.
For the purposes of the current study, the MFA, MAD, CAS, CLS and SAS metrics
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were instead applied to treatments planned using the AAA algorithm in the Varian
Eclipse treatment planning system.
3. Results
The results of comparing the GAI values from QA testing with the treatment plan
complexity, deliverability and accuracy metrics are shown in figures 1, 2, and 3. Figure
1 shows the fluence map metric MI, figure 2 shows the leaf positioning metric MCS, and
figure 3 shows aperture based metrics CAS, MAD and SAS calculated using a 10mm
threshold.
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Figure 1. Relationship between GAI calculated using acceptance criteria of 3%,3mm
and MI for (a,b,c) IMRT and (d) VMAT beams according to treatment site: anus
(orange cross markers), brain (purple circle markers), endometrium (green triangle
markers), head and neck (blue diamond markers), and prostate (red square markers).
In figures 1(a)-(d) the QA results are shown for the IMRT and VMAT beams,
plotted against beam fluence complexity, represented as MI. In all four figures, MI shows
an overall trend of decreasing with increasing GAI, indicating that QA higher pass rates
are achieved by less complex beams, although this trend is statistically significant for
the IMRT beams only (see table 2). Data shown in figures 2(a)-(c) suggest that MI
can distinguish between treatments for different anatomical sites, with anus/rectum
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Figure 2. Relationship between GAI calculated using acceptance criteria of 3%,3mm
and MCS for (a) IMRT and (b) VMAT beams, and relationship between AAV and
MCS for (c) IMRT and (d) VMAT beams, according to treatment site: anus (orange
cross markers), brain (purple circle markers), endometrium (green triangle markers),
head and neck (blue diamond markers), and prostate (red square markers).
and endometrium treatment beams delivering generally more complex fluences than the
prostate and brain treatment beams.
Figures 2(c) and (d) show the AAV, one of the two components of the MCS, plotted
against MCS. The linear relationship between these data indicates that the MCS is
largely determined by MLC aperture variability, with interdigitation of leaves (described
by LSV, the other component of the MCS) varying more weakly between beams.
In contrast to the fluence map based results of figure 1, the leaf positioning MCS
results shown in figures 2(a) and (b) do not clearly distinguish between treatments for
different anatomical sites. There is a statistically significant trend (see table 2), with
an increasing MCS (a decreasing complexity) correlated with a increasing gamma pass
percentage.
Figure 3 shows that there are general trends towards decreasing CAS and decreasing
MAD with increasing GAI, as shown in figures 3(a) and (b), suggesting that plans with
less asymmetric MLC apertures and fewer exposed leaves crossing the central axis result
in more accurate delivery of the planned doses. Figure 3(c) confirms this geometric
relationship between the CAS and MAD.
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Figure 3. (a) Relationship between GAI calculated using acceptance criteria of
3%,3mm and CAS for IMRT beams. (b) Relationship between GAI calculated using
acceptance criteria of 3%,3mm and MAD for IMRT beams. (c) Relationship between
MAD and CAS for IMRT beams. (d) Relationship between GAI calculated using
acceptance criteria of 3%,3mm and SAS calculated with a 10 mm threshold for IMRT
beams. Data is labelled according to treatment site: anus (orange cross markers),
brain (purple circle markers), endometrium (green triangle markers), head and neck
(blue diamond markers), and prostate (red square markers).
While average MLC aperture sizes are generally larger for the VMAT beams than
for the IMRT beams, especially for anus and rectum treatments, the mean field area
metric has no significant correlation with QA results (see table 2). There are, however,
statistically significant correlations between the proportions of each beam that are
comprised of small apertures for both IMRT beams (when “small” is defined as either
narrower than 1 mm, less than 5 mm or less than 10 mm) and VMAT beams (when
“small” is defined as narrower than 1 mm). In these treatments, decreasing small
aperture scores are correlated (see table 2) with increasing GAIs, as exemplified in
figure 3(d).
The effect that the proportion of small apertures in each beam has on the
modulation and complexity of IMRT beams is shown in figures 4(a) and (b). Figure
4(a) suggests an inconsistent relationship between SAS and MI, with beam modulation
increasing with increasing proportion of small apertures for prostate, head and neck and
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Figure 4. (a) Relationship between MI and SAS for IMRT beams. (b) Relationship
between MCS and SAS for IMRT beams. (c) Relationship between MCS and SAS for
VMAT beams evaluated as entire 360◦ arcs. (d) Relationship between MCS and SAS
for VMAT beams evaluated as 60◦ sub-arcs. SAS has been calculated using a 10 mm
threshold. Data is labelled according to treatment site: anus (orange cross markers),
brain (purple circle markers), endometrium (green triangle markers), head and neck
(blue diamond markers), and prostate (red square markers).
anus treatment beams only, while an inverse relationship is apparent in the results for
the endometrium treatment beams. Figure 4(b) illustrates a strong inverse relationship
between SAS and MCS, with the beams with more complex MLC arrangements (lower
MCS values) being comprised of larger proportions of small apertures (higher SAS
values). Figures 4(c) and (d) indicate that this relationship also holds for the VMAT
beams, even when they are evaluated as 60◦ sub-arcs.
Table 2 quantifies the significance of correlations between calculated metrics and
the QA data by listing F -test statistics. Data in table 2 indicate that while the QA
results for the IMRT beams are significantly correlated with the beam complexity (MI)
and deliverability (MCS, AAV) as well as the proportion of small and asymmetric MLC
apertures in the beam (SAS, MAD, CAS), the QA results for the VMAT beams are not
strongly correlated with any of the metrics evaluated except the MCS. The VMAT QA
results’ apparent insensitivity to beam modulation and composition holds even when
the arcs are evaluated as series of 60◦ sub-arcs.
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Table 2. Summary of F statistic tests for significant linear relationships between
metric values and GAI for beams. Significance is evaluated against Sˇida´k corrected
α values of approximately 0.004 (*), 0.0008 (**) and 0.00008 (***), corresponding to
experiment-wide α values of 0.05, 0.01 and 0.001 respectively.
VMAT VMAT Sub-arc Sub-arc IMRT IMRT
Metric 3%,3mm 2%,2mm 3%,3mm 2%,2mm 3%,3mm 2%,2mm
# Plans 70 70 19 19 52 52
# Beams 144 144 207 207 402 402
MU ns ns ns ns *** ***
MFA ns ns ns ns ns ns
AAV ns ns ns ns *** ***
CLS ns ns ns ns ns ns
CAS ns ns ns ns *** ***
FMC ns ns *** ** ns ns
MAD ** *** ns ns *** ***
MCS ** ns *** *** *** **
MI * ** ns ns *** ***
SAS1 * * * * *** ***
SAS5 ns ns ns ns *** ***
SAS10 ns ns ns ns *** ***
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Figure 5. (a) Relationship between GAI calculated for whole arcs and GAI calculated
for corresponding sub-arcs, for both 3%,3mm (blue circle markers) and 2%,2mm (red
square markers) criteria. Dashed line indicates 1:1 relationship. Linear coefficient is
1.025 for 3%,3mm data and 1.050 for 2%,2mm data (assuming zero constant).
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Table 3. GAI values calculated for whole arcs and corresponding sub-arc GAI sets,
for both 3%,3mm and 2%,2mm. Significance of difference is evaluated between whole
and divided sub-arc pairings using a two-tailed Welch’s t-test.
3%,3mm 2%,2mm
Whole arc (360◦) GAI 95.9% 90.0%
Sub-arc (60◦) maximum GAI 96.0% 89.2%
Significance ns ns
Sub-arc (60◦) mean GAI 93.5% 85.4%
Significance ** ***
Sub-arc (60◦) minimum GAI 90.6% 80.8%
Significance *** ***
The relationship between whole 360◦ rotation GAIs and the GAI for 60◦ sub-arcs
is presented in figure 5 for 3%,3mm and 2%,2mm. Over each set of data, the agreement
with measurements is improved when the entire arc is delivered, by 2.5% and 5.3% when
comparing against the mean GAI of the sub-arcs (at 3%,3mm and 2%,2mm). The data
is summarised in table 3.
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Figure 6. Relationship between GAI calculated using acceptance criteria of 3%,3mm
and GAI calculated using acceptance criteria of 2%,2mm for IMRT beams (orange
crosses), VMAT sub arcs (red filled circles) and whole VMAT arcs (blue open circles).
Dashed line indicates 1:1 relationship. Linear coefficient is 1.085 ± 0.002, with a
coefficient of determination of 0.998.
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Table 4. Relationship between GAI calculated using acceptance criteria for IMRT
and VMAT beams (both whole and sub- arcs). r2 is the coefficient of determination.
3%,3mm 2%,2mm Linear
Treatment Mean GAI Mean GAI Coefficient r2
IMRT 96.48% 88.91% 1.082 ± 0.002 0.998
Whole arc (360◦) 95.34% 87.78% 1.083 ± 0.005 0.998
Sub-arc (60◦) 93.49% 85.32% 1.094 ± 0.003 0.999
Total 95.44% 87.70% 1.085 ± 0.002 0.998
The relationship between GAI using acceptance criteria of 3%,3mm and 2%,2mm
is shown in figure 6 and table 4. These results suggest that, when an evaluation of
the agreement between the planned dose and the dose measured in a two-dimensional
plane within a homogeneous phantom is completed using 2%,2mm criteria, the resulting
GAI are generally (with few exceptions) close to 8% lower than the GAI resulting
from an evaluation using 3%,3mm criteria. In other words, for the treatment plans
examined in this study, the use of a 90% pass rate for QA tests using 3%,3mm criteria
is approximately equivalent to the use of 82% pass rate for QA tests using 2%,2mm
criteria.
4. Discussion
4.1. Effects of anatomical site
Comparison of most of the results for different anatomical sites indicates that the anus,
rectum, head and neck treatment beams were generally more complex, with modulated
fluences produced by combining larger numbers of asymmetric field apertures, than the
prostate endometrium and brain treatment beams. Specifically, data in figures 3(a)
and (b) show that for the treatment plans used in this study, the beams designed to
treat larger volumes use larger proportions of MLC leaves that block the central axis to
produce beam apertures that are displaced off-axis by greater distances than the beams
designed to treat smaller volumes. IMRT beams from the endometrium, anus and head
and neck treatments were found to produce most of the high SAS results (see figure
3(d)), most of the high MI results (see figures 1(b) and (c)) and many of the low AAV
results (see figure 2(c)) seen in this study.
The apparent stratification of the MCS results for different anatomical sites
(especially for the IMRT beams) shown in figures 2(c)-(d) and 4(b)-(d) similarly suggest
an increase in the complexity of MLC arrangements for increasing treatment volume
(from the beams from the prostate plans to the beams from the brain plans to the
beams from the anus and endometrium plans), which reflect the differences between
MCS values from head and neck plans and prostate plans that were observed in the
original description of the MCS by McNiven et al. (2010) and the more recent phantom
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study by McGarry et al. (2011).
In this study, all of the IMRT beams that failed their QA tests (GAI < 90%) came
from treatment plans for the anus and rectum and head and neck regions, where large
targets including lymph nodes are treated using relatively large and sometimes split
radiation fields. Data in figure 3(a) show that all of these failing beams involved MLC
leaves that were closed across the central axis more than they were open away from the
central axis (with cross axis scores substantially greater than 0.5). Data in figures 1(a)
and 3(a)-(b) show that the failing anus and rectum treatment beams are quantitatively
different (more modulated, with more asymmetric MLC positions and more closed MLC
leaves per beam) from the passing anus and rectum treatment beams.
Overall, anus, rectum, head and neck treatments contributed the majority of
VMAT arcs that failed their QA tests, suggesting that the increased complexity of the
treatments planned for larger target volumes, with correspondingly decreased proximity
to neighbouring organs at risk, unavoidably leads the treatment planning systems
optimisation engine to produce modulated beam fluences that are more difficult for
the treatment delivery system to reproduce than the beam fluences planned for smaller
treatment volumes with fewer or less highly prioritised organs at risk.
4.2. Effects of treatment modality
Data in table 2 suggest that many of the complexity, deliverability and calculation
accuracy metrics investigated in this study are strongly correlated with GAI results
from QA testing of the IMRT beams, but few of the metrics are correlated with GAI
results from QA testing of the VMAT beams, whether they are evaluated as whole 360◦
arcs or as 60◦ sub-arcs.
For example, for the IMRT beams, strong correlations between small aperture
scores and GAI results indicates that beams with fewer small MLC apertures are more
accurately delivered than beams comprised of larger proportions of small apertures.
This result, obtained from the analysis of 402 beams from treatments for five different
anatomical sites, verified using a high-resolution EPID-based pre-treatment QA system,
provides broad confirmation of the results of a previous study that used only 151 beams,
from prostate and cranial treatments only, verified using measurements made with a
low-resolution diode array (Kairn et al. 2014).
For the IMRT beams used in this work, the small aperture score potentially provides
useful thresholds for predicting likely QA outcomes; all IMRT beams pass their QA
tests when the small aperture score (with small defined as less than 10 mm) is less than
0.2. Examination of previously published results (Crowe et al. 2014) indicates that a
threshold SAS value of 0.2 also identifies accurate and deliverable prostate IMRT beams
(with 100% specificity) from treatments planned with the Brainlab iPlan treatment
planning system (using a pencil beam algorithm) for delivery using a Brainlab m3
microMLC. These results suggest that the SAS (and the 0.2 threshold value, for small
apertures defined as less than 10 mm) may be used to provide treatment planning
Properties of IMRT and VMAT beams 14
guidance at centres using systems other than Varian Eclipse (with AAA) and the
MIllennium MLC.
By contrast, small aperture scores are generally poorly correlated with the GAI
results for VMAT arcs. Comparison of figures 1(a)-(c), 2(a) and 4(b) with figures 1(d),
2(b) and 4(c) indicate that the IMRT beams generally produced higher values of metrics
correlated with GAI (specifically, the SAS, MCS and MI) than were produced by the
VMAT arcs. It is possible that the absence of statistically significant relationships
between the GAI values for the VMAT arcs and the metrics evaluated in this work
arises from the VMAT arcs being less modulated and using fewer small and asymmetric
MLC apertures than were used in the IMRT beams.
4.3. Effects of analysis procedure
The general reduction in the GAI values produced by the VMAT plans, when evaluated
as 60◦ sub-arcs (as opposed to when evaluated as the entire planned 360◦ arcs), which is
illustrated in figure 5, may arise from a genuine increase in treatment delivery inaccuracy
due to the increased proportion of each beam that is involved in starting and stopping,
including the ramping up and down of linac output (Kang et al. 2008), gantry speed
and MLC motion. However, the fact that Nicolini et al. (2008) did not find a similar
discrepancy in the evaluation of a small number of sub-arcs (3) with shorter gantry
rotations (6◦ and 12◦), despite using similar beam delivery and QA systems, suggest that
variations in the performance of the delivery system when delivering arcs of different
lengths is unlikely to be the cause of the trend seen in figure 5. Rather, is possible that
evaluation of the VMAT plans using sub-arcs reveals disagreements between the planned
and delivered doses that are cancelled or averaged out when the entire arc is delivered.
This possibility warrants further investigation, since any undetected warping of the dose
distribution that could result from increased doses at some angles and decreased doses
at others has the potential to result in increased target dose heterogeneity or decreased
organ-at-risk sparing.
The linear relationship between GAIs calculated from the quality assurance images
using 3%,3mm and 2%,2mm acceptance criteria, shown in figure 6, has an approximately
8% gradient for both the IMRT and the VMAT beams. Masi et al. (2013) reported a
7.7% decrease in mean GAI when the gamma evaluation criteria were tightened from
3%,3mm to 2%,2mm for 142 VMAT treatment plans evaluated using a low-resolution
biplanar diode array. These results suggest that a change in gamma acceptance
criteria from 3%,3mm to 2%,2mm is, for most of the beams evaluated in this work,
approximately equivalent to tightening the QA passing threshold by 8%. This important
result suggests that QA results achieved by different centres using different gamma
criteria may be more easily comparable than expected.
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5. Conclusions
The large number of treatment plans evaluated in this study allowed an examination of
the interrelationships between various new and established modulated beam complexity,
deliverability and accuracy metrics and the QA measurement results that many of the
metrics were designed to predict.
Variations in metric values were observed for different anatomical treatment
sites, suggesting that poorer QA outcomes for anus, endometrium and head and
neck treatments arise from the planning system’s reliance on more modulated beams
consisting of more asymmetric MLC apertures than are needed to cover smaller, less
geometrically challenging target volumes.
The IMRT results were able to provide clinically useful guidelines for future
treatment planning. In order to produce dosimetrically accurate and clinically
deliverable IMRT beams, planners should aim to achieve values of MI less than 0.02,
values of MCS greater than 0.4 and CAS less than 0.7. Values of SAS (with MLC
apertures narrower than 10 mm defined as “small”) less than 0.2 also identified QA
passing IMRT beams with 100% specificity. Plans that fail to meet one or more of
these criteria may be automatically replanned or sent for QA testing, depending on
local planning and treatment workloads. These criteria also may be broadly applicable
to treatment planning and delivery systems other than those used in this study.
Few statistically significant relationships between QA results and beam complexity
metrics were identified in the VMAT data, however quarterly review of mean MI, MCS,
CAS or SAS values for VMAT plans generated over the preceding three months may
prove useful as a means of identifying trends or changes in planning technique or
optimiser performance. Additionally, these metrics could prove useful in identifying
changes in optimiser performance after any changes or updates to treatment planning
software.
Appendix: List of initialisms
• AAV: aperture area variability
• CAS: cross axis score
• CLS: closed leaf score
• FMC: fluence map complexity
• GAI: gamma agreement index
• MAD: mean aperture displacement
• MCS: modulation complexity score
• MFA: mean field area
• MI: modulation index
• SAS: small aperture score
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